ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial
16 août 2017 08h30 HE
|
ARCA Biopharma, Inc.
GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018 WESTMINSTER,...
ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis
09 août 2017 16h30 HE
|
ARCA Biopharma, Inc.
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018Gencaro Development Program Has Been Granted Fast Track Designation by U.S. FDA WESTMINSTER, Colo., Aug. 09, 2017 (GLOBE...
ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017
20 juin 2017 08h30 HE
|
ARCA Biopharma, Inc.
GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation Gencaro Development Program Previously Granted Fast Track Designation by U.S. FDA ...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
15 mai 2017 08h30 HE
|
ARCA Biopharma, Inc.
WESTMINSTER, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
UCHealth is Colorado's first health system to implant new device to prevent strokes
23 févr. 2016 11h08 HE
|
UCHealth
AURORA, Colo., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Heart specialists at UCHealth's Medical Center of the Rockies and University of Colorado Hospital are the first in the region to implant a new device...
Survey Reveals How AFib Patients Age 65+ View Risks, Diagnosis, and Treatment
24 févr. 2015 09h08 HE
|
Alliance for Aging Research
WASHINGTON, DC,, Feb. 24, 2015 (GLOBE NEWSWIRE) -- A survey released by the nonprofit Alliance for Aging Research of more than 500 patients age 65 and over with atrial fibrillation (AFib) reveals...
Top U.S. Heart Treatment Centers, Patient Group, Form Alliance to Improve Irregular Heartbeat Care
18 juin 2014 06h00 HE
|
National Alliance of Integrated AFib Centers
NORFOLK, VA--(Marketwired - Jun 18, 2014) - National Alliance of Integrated AFib Centers
Overview
Top U.S. heart centers implement a collaborative,...
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
27 févr. 2014 08h00 HE
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace® system for MRI-guided, catheter-based cardiac procedures will be...
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
24 févr. 2014 08h00 HE
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software...
American Heart Association/American Stroke Association Survey Reveals Positive Results on Patient Perception of Risks Associated Between Atrial Fibrillation and Stroke
05 sept. 2012 08h00 HE
|
American Heart Association
DALLAS, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial...